Skip to main content
Journal cover image

Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary Arteries.

Publication ,  Journal Article
Hochrein, J; Sun, F; Pieper, KS; Lee, KL; Gates, KB; Armstrong, PW; Weaver, WD; Goodman, SG; Topol, EJ; Califf, RM; Granger, CB; Wagner, GS
Published in: Am J Cardiol
May 1, 1998

Increased T-wave amplitude is one of the earliest electrocardiographic (ECG) changes following coronary artery occlusion. Therefore, higher T waves in the presenting electrocardiogram should represent earlier time to treatment and thus be associated with lower mortality following thrombolytic therapy. However, T-wave amplitude has never been evaluated as a prognostic marker in this setting. We examined clinical outcomes in 3,317 patients with acute myocardial infarction (AMI) who underwent thrombolysis in the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO-I) Study. Patients were classified as either those with high T waves or those with low T waves. Higher T waves were defined as those >98th percentile of the upper limit of normal. T-wave amplitude was also evaluated as a continuous variable according to infarct location (maximum T-wave amplitude) and as the amount of excess T-wave amplitude above normal (excess T-wave amplitude). Patients with higher T waves had lower 30-day mortality than those without (5.2% vs 8.6%, p = 0.001) and were less likely to develop congestive heart failure (15% vs 24%, p <0.001) or cardiogenic shock (6.1% vs 8.6%, p = 0.023). Higher maximum T-wave amplitude and excess T-wave amplitude were predictive of lower 30-day mortality (chi-square = 67, p <0.001 and chi-square = 33, p <0.001, respectively). These differences remain significant after controlling for other prognostic baseline ECG variables. In addition, T-wave amplitude added prognostic significance after controlling for time to treatment. T-wave amplitude, an often-overlooked component of the electrocardiogram, can add significant prognostic information in initial evaluation of patients with AMI.

Duke Scholars

Published In

Am J Cardiol

DOI

ISSN

0002-9149

Publication Date

May 1, 1998

Volume

81

Issue

9

Start / End Page

1078 / 1084

Location

United States

Related Subject Headings

  • Thrombolytic Therapy
  • Randomized Controlled Trials as Topic
  • Prognosis
  • Myocardial Infarction
  • Multicenter Studies as Topic
  • Middle Aged
  • Male
  • Logistic Models
  • Humans
  • Heart Conduction System
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hochrein, J., Sun, F., Pieper, K. S., Lee, K. L., Gates, K. B., Armstrong, P. W., … Wagner, G. S. (1998). Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary Arteries. Am J Cardiol, 81(9), 1078–1084. https://doi.org/10.1016/s0002-9149(98)00112-x
Hochrein, J., F. Sun, K. S. Pieper, K. L. Lee, K. B. Gates, P. W. Armstrong, W. D. Weaver, et al. “Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary Arteries.Am J Cardiol 81, no. 9 (May 1, 1998): 1078–84. https://doi.org/10.1016/s0002-9149(98)00112-x.
Hochrein J, Sun F, Pieper KS, Lee KL, Gates KB, Armstrong PW, Weaver WD, Goodman SG, Topol EJ, Califf RM, Granger CB, Wagner GS. Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary Arteries. Am J Cardiol. 1998 May 1;81(9):1078–1084.
Journal cover image

Published In

Am J Cardiol

DOI

ISSN

0002-9149

Publication Date

May 1, 1998

Volume

81

Issue

9

Start / End Page

1078 / 1084

Location

United States

Related Subject Headings

  • Thrombolytic Therapy
  • Randomized Controlled Trials as Topic
  • Prognosis
  • Myocardial Infarction
  • Multicenter Studies as Topic
  • Middle Aged
  • Male
  • Logistic Models
  • Humans
  • Heart Conduction System